280 related articles for article (PubMed ID: 1349662)
1. The treatment of hairy cell leukemia: an update.
Golomb HM; Ratain MJ; Mick R; Daly K
Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
[TBL] [Abstract][Full Text] [Related]
2. Hairy cell leukemia 1992.
Spielberger RT; Golomb HM
Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
[TBL] [Abstract][Full Text] [Related]
3. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
[TBL] [Abstract][Full Text] [Related]
5. Hairy cell leukaemia: review of treatment.
Kurzrock R; Talpaz M; Gutterman JU
Br J Haematol; 1991 Oct; 79 Suppl 1():17-20. PubMed ID: 1718389
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
7. Advances in therapy for hairy cell leukemia. A review.
Jaiyesimi IA; Kantarjian HM; Estey EH
Cancer; 1993 Jul; 72(1):5-16. PubMed ID: 7685243
[TBL] [Abstract][Full Text] [Related]
8. [Alpha interferon treatment in hairy cell leukemia].
Hagberg H
Nord Med; 1992; 107(3):74-5. PubMed ID: 1347920
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
10. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
11. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
12. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
Piro LD; Carrera CJ; Carson DA; Beutler E
N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
14. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hairy-cell leukemia.
Lill MC; Golde DW
Blood Rev; 1990 Dec; 4(4):238-44. PubMed ID: 1706207
[TBL] [Abstract][Full Text] [Related]
16. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
18. Hairy cell leukemia. What is new forty years after the first description?
Troussard X; Maloisel F; Flandrin G
Hematol Cell Ther; 1998 Aug; 40(4):139-48. PubMed ID: 9766918
[TBL] [Abstract][Full Text] [Related]
19. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
20. Red cell distribution width (RDW) as a marker of disease activity in patients with hairy cell leukemia.
Chrobák L; Zák P; Podzimek K; Stránský P
Acta Medica (Hradec Kralove); 1998; 41(1):23-6. PubMed ID: 9588069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
